What is the ONC.TO share price today?

This page shows the latest available Oncolytics Biotech Inc. (ONC.TO) price with its change against the prior close. Values are delayed or previous-close, not real-time.

Where is Oncolytics Biotech Inc. listed?

Oncolytics Biotech Inc. trades on the Toronto Stock Exchange under the symbol ONC.TO, ISIN CA6823108759.

How large is Oncolytics Biotech Inc.?

Its market capitalisation is approximately 142.25M CAD, based on the latest available price and share count from our data provider.

Toronto Stock Exchange (TSX) · ONC.TO · ISIN CA6823108759

Oncolytics Biotech Inc.

No trading activity has been reported for this listing since August 22, 2025. It may be delisted, halted or inactive.

1.42 CAD

August 22, 2025

Oncolytics Biotech Inc. (ONC.TO) trades on the Toronto Stock Exchange and operates in the Biotechnology industry. Its market capitalisation is approximately 142.25M CAD. The company reports around 28 employees. Its ISIN is CA6823108759. This page shows the latest available price, the day and 52-week ranges and an interactive chart. Quotes are delayed and are not intended for order execution.

Key facts

Exchange

Toronto Stock Exchange (TSX)

ISIN

CA6823108759

Sector

Healthcare

Industry

Biotechnology

Country

Market cap

142.25M CAD

Employees

Previous close

1.39 CAD

Day range

1.39 – 1.44

52-week range

0.45 – 2.08

Volume

109.63K

50-day average

1.31 CAD

200-day average

1.08 CAD

Asset type

Equity

About Oncolytics Biotech Inc.

Oncolytics Biotech Inc. is a biopharmaceutical firm in its development stage, dedicated to researching and creating medicinal therapies for cancer. The company's primary asset is pelareorep, an immunotherapeutic agent administered intravenously to combat both solid tumors and blood cancers. Oncolytics Biotech maintains a collaborative development pact with Merck KGaA and Pfizer Inc. This collaboration aims to advance pelareorep when combined with paclitaxel and avelumab—a human anti-PD-L1 antibody—specifically for addressing metastatic breast cancer that is hormone receptor-positive and human epidermal growth factor 2-negative. Additionally, the company partners with PrECOG LLC. Established in 1998, the enterprise operates from its main office in Calgary, Canada.

Company website

Frequently asked

What is the ONC.TO share price today?: This page shows the latest available Oncolytics Biotech Inc. (ONC.TO) price with its change against the prior close. Values are delayed or previous-close, not real-time.
Where is Oncolytics Biotech Inc. listed?: Oncolytics Biotech Inc. trades on the Toronto Stock Exchange under the symbol ONC.TO, ISIN CA6823108759.
How large is Oncolytics Biotech Inc.?: Its market capitalisation is approximately 142.25M CAD, based on the latest available price and share count from our data provider.

All Oncolytics Biotech Inc. data comes from exchange and provider feeds for the Toronto Stock Exchange and is published for information, not as investment advice.

Real-time quotes are not licensed; prices are delayed or previous close, so they may lag the market by 15 minutes or a full session. Information only, not for trading. Where a figure is not covered by our licensed sources, the page says so rather than showing a substitute.